Professional Experience:

2008 ? present. CEO & President, Elements Behavioral Health and ÿPromises Treatment Centers

A private equity backed company providing treatment solutions for individuals with emotional and addictive disorders. Treatment centers are Promises Treatment Centers, The Ranch at Piney River, The Recovery Place, and The Sexual Recovery Institute.

2006 President, Eating Disorders Ventures LLC

A joint venture with Aspen Education Group, Inc., Cerritos, California. Development and manage Eating Disorder treatment programs. Acquired by CRC Heath Group ÿ11/06.

2000 ? 2005 Chief Medical Officer, National Director of Clinical Research, Comprehensive NeuroScience, Inc., White Plains, NY.

Supervised all aspects of clinical trials programs specializing in disorders of the central nervous and clinical pharmacology. Responsibilities included oversight of protocol design, feasibility, regulatory compliance, safety. Oversight of 70 bed Phase I unit and 9 Phase II-IV sites.

1994 ? 1999 Principal Investigator

Clinical trials program focused on central nervous system diseases, in Cerritos, CA. Key accomplishments: Successful enrollment, retention and separation from placebo in numerous pivotal trials of antipsychotic medications, mood stabilizers, antidepressants, cognitive and sedative hypnotic medications.

1998 ? 2001 Senior Vice President, Clinical Services, Aspen Education Group, Cerritos, CA

Built and managed the operations of the Community Services Division, the largest privately owned network of publicly funded mental health centers in California, specializing in the treatment of high risk youth.

1993 ? 2001 President and Medical Director, College Health IPA, Cerritos, CA

A managed behavioral health group practice. ÿWrote the utilization/managment guidelines and supervised clincal operations. Directly surpervised credentialling and care management. Developed financial models used to negotiate and manage capatiated and risk contracts for behavioral services. Developed a statewide provider network in California. In addition successfully implemented instensive rehabiliation programs and substance abuse treatment programs contracted to County Mental Health Agencies.

1982 ? 1999 Private Practice Experience

Inpatient and outpatient treatment of patients with mood, anxiety and thought disorders. Developed and supervised ambulatory detoxification and substance abuse treatment programs. Extensive experience with treatment resistant depression including the use of electroconvulsive therapy.

1993 ? 1999 Senior Medical, Director,ÿCollege Hospital, Cerritos, CA

Responsible for professional affairs, regulatory compliance and managed care contracting. Directly supervised credentialing, peer review and professional conduct, development of policies and procedures, and survey preparation.

1987 ? 1993 Medical, Director, Los Altos Hospital and Mental Health Center, Long Beach, CA

Responsible for medical affairs and regulatory compliance. Key Accomplishments: Awarded Best New Hospital recognition by national hospital corporation. Implemented specialized programs for Panic disorder and Post-traumatic stress disorder. Authored book on adult victims of sexual abuse. Implemented a successful electroconvulsive therapy program despite a hostile regulatory environment.

1983 ? 1987 Chief, Inpatient Unit, Clinical Psychobiology Branch, National Institute of Mental Health Bethesda, MD

Supervised all research trials conducted on an inpatient mental health unit at the Clinical Center, NIH. Conducted independent research in biological rhythms, photobiology, and sleep deprivation.

Education:

1981 ? 1983 ÿ Fellowship: Psychopharmacology, National Institute of Mental Health, Bethesda, MD

1979 ? 1981 ÿ Residency: Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, CA

1978 ? 1979 ÿ Internship: Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, CA

1978 ÿ MD, Rush Medical College, Chicago, IL

1974 ÿB.A. Psychology, Suma Cum Laude, SUNY at Buffalo, Buffalo, NY

Licensure and Certifications:

10-31-2006 Sacramento, CA. 95825-3236, License# G40374

02-28-2005 DEA License# AS9033983

Diplomat: American Board of Addiction Medicine, 2010

Diplomat: American Society of Addiction Medicine, 2000

Diplomat: Added Qualification in Addiction Psychiatry, American Board of Psychiatry and Neurology, 1994, 2008

Diplomat: Added Qualification in Geriatric Psychiatry, American Board of Psychiatry and Neurology, 1991, 2001

Diplomat: Psychiatry, American Board of Psychiatry and Neurology, January, 1984

Honor: 1978 ? Phi Beta Kappa

PUBLICATIONS

1. Schauf CL, Davis FA, Sack DA, Reed BT, Kesler RL: Neuroelectric blocking factors in human and sera evaluated using the isolated frog spinal chord. Journal of Neurology, Neurosurgery, and Psychiatry, 39: 680-685, 1976.

2. Scharfstein SS, Sack DA, Fauci AS: Relationship between alternate day corticosteroid therapy and behavioral abnormalities. Journal of the American Medical Association, 248: 2987-2989, 1982

3. Wehr TA, Sack DA, Rosenthal NE, Duncan WK, Gillin JD, Gillin JC: Circadian rhythm disturbances in manic-depressive illness. Federation Proceedings, 42: 2809-2814, 1983.

4. Rosenthal NE, Sack DA, Wehr TA: Seasonal Variation in affective disorders, in Wehr TA, Goodwin FK (eds.), Biological Rhythms in Psychiatry, Boxwood Press, Pacific Grove, California, 1983, pp. 185-201.

5. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Newsome DA, Wehr TA: Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry, 41: 72-80, 1984.

6. Rosenthal NE, Sack DA, Carpenter CJ, Parry BL, Mendelson WB, Wehr TA: Antidepressant effects of light in seasonal affective disorder. American Journal of Psychiatry, 142: 06-608, 1985.

7. Wehr TA, Sack DA, Duncan W, Rosenthal NE, Gillin JC, Goodwin FK: Sleep and circadian rhythms in affective patients isolated from external time cues. Psychiatry Research, 15: 327-339, 1985

8. Sack DA, Nurnburger J, Rosenthal NE, Ashburn E, Wehr TA: The potentiation of antidepressant medications by phase-advance of the sleep-wake cycle. American Journal of Psychiatry, 142: 606-608, 1985

9. Wehr TA, Rosenthal NE, Sack DA, Gillin JC: Antidepressant effects of sleep deprivation in bright and dim light. Acta Psychiatrica Scandinavica, 72: 161-165, 1985.

10. James SP, Wehr TA, Sack DA, Parry BL, Rosenthal NE: Evening light treatment of seasonal affective disorder. British Journal of Psychiatry, 147: 424-428, 1985.

11. Strauss GD, Sack DA, Lesser I: Which veterans go to VA psychiatric hospitals for care: a pilot study. Hospital Community Psychiatry, Sept. 1985.

12. Golden RN, James SP, Sherer MA, Rodorfer MV, Sack DA, Potter WZ: Psychosis associated with bupropion treatment. American Journal of Psychiatry, Dec. 1985

13. Rosenthal NE, Sack DA, Wehr TA: Seasonal effects on mood: The role of light in Adelman G(ed.), Encyclopedia of Neuroscience, Birkhauser, Boston.

14. Wehr TA, Sack DA, Rosenthal NE: Antidepressant effects of sleep deprivation and phototherapy. Acta Psychiatrica Belgica, 85, 593-602, 1985.

15. Wehr TA, Sack DA, Parry BL, Rosenthal NE: The role of biological rhythms in the biology and treatment of insomnia and depression, in Brodie HKH, Berger PA (eds.), The American Handbook of Psychiatry.

16. Rosenthal NE, Sack DA, Jacobsen FM, James SP, Parry BL, Arendt J, Tamarkin L, Wehr TA: The role of melatonin in seasonal affective disorder. Journal of Neural Transmission.

17. James SP, Wehr TA, Sack DA, Rosenthal NE, Mendelson WB: Experimental modalities in the treatment of seasonal and non-seasonal affective disorder. Proceedings of the World Congress of Biological Psychiatry.

18. Mendelson WB, James SP, Rosenthal NE, Sack DA, Wehr TA, Garnett D, Weingartner H: The experience of insomnia. Proceedings of the World Congress of Biological Psychiatry.

19. Rosenthal NE, Sack DA, Jacobsen FM, Parry BL, James SP, Tamarkin L, Arendt J, Wehr TA: Consensus and controversy in seasonal affective disorder and phototherapy. Proceedings of the World Congress of Biological Psychiatry.

20. Sack DA, James SP, Rosenthal NE, Wehr TA: Partial sleep deprivation and phase advance therapy for depression. Proceedings of the World Congress of Biological Psychiatry.

21. James SP, Wehr TA, Sack DA, Parry BL, Rogers SLB, Rosenthal NE: The dexamethasone suppression test in seasonal affective disorder. Comprehensive Psychiatry, 27: 224-226, 1986.

22. Mendelson WB, James SP, Garnett D, Sack DA, Rosenthal NE: A pyshcophysiological study of insomnia. Psychiatry Res., Dec. 1986.

23. Wehr TA, Jacobsen FM, Sack DA, Arendt J, Tamarkin L, Rosenthal NE: Phototherapy of seasonal affective disorder. Time and day suppression of melatonin are not critical for antidepressant effects. Arch Gen Psychiatry Sept. 1986.

24. Roy-Bryne PP, Uhde TW, Sack DA, Linnoila M, Post RM: Plasma HVA and anxiety in patients with panic disorder. Biol Psychiatry, July 1986.

25. Rosenthal NE, Sack DA, Jacobsen FM, Skwerer RG, Wehr TA: Seasonal affective disorder and light: past, present, and future. Clin Neuropharmacol, Sept. 1986.

26. Wehr TA, Sack DA: The relevance of sleep research to affective illness. In Sleep, 1986, Koella WP, Obal F, Schula H, Visser P, eds.

27. Wehr TA, Sack DA: Jacobsen F, Tamarkin L, Arendt J, Rosenthal NE: Timing of phototherapy and its effect on melatonin secretion are not critical for its antidepressant effect in seasonal affective disorder. Archives of General Psychiatry, 43: 870-875.

28. Wehr TA, Sack DA, Rosenthal NE: Sleep and biological rhythms in bipolar illness, in Goodwin FK, Jamison K (eds.): Bipolar Disorders, in Hales RE, Frances AJ (eds.): American Psychiatric Association Press, Washington, D.C.

29. Sack DA, Wehr TA. Circadian rhythms in psychiatry. In Depression and Mania: A Comprehensive Textbook, Georgotas A, Concro R (eds.), Elsevier Science Publishing Co., New York.

30. Jacobsen FM, Wehr TA, Sack DA, James SP, Parry BL, Rosenthal NE: Seasonal affective disorder in the workplace: implications for public health. American Journal of Public Health, 77: 57-60, 1987.

31. Wehr TA, Sack DA, Rosenthal NE: Sleep reduction as a final common pathway in the genesis of mania. American Journal of Psychiatry, 144: 201-204, 1987.

32. Sack DA, Rosenthal NE, Parry BA, Wehr TA: Biological Rhythms in Psychiatry. In: Psychopharmacology. A second generation of progress.

33. Rosenthal NE, Sack DA, James SP, Parry BL, Mendelson WB, Tamarkin L, Wehr TA: Seasonal affective disorder and phototherapy. Annals of the New York Academy of Sciences, 453: 260-269, 1985.

34. James SP, Golden RN, Sack DA: Vitamin B12 deficiency and the dexamethasone test. Journal of Nervous and Mental Diseases, 174: 560-561, 1986.

35. Wehr TA, Sack DA, Rosenthal NE, Goodwin FK: Sleep and biological rhythms in bipolar disorder, Annual Review, Volume 6, American Psychiatric Association, Washington, D.C., 1986.

36. Sack DA, Rosenthal NE: Do changes in melatonin cause SAD? Intergrative Psychiatry, 1: 35-37, 1987.

37. Wehr Tam Skwerer RG, Jacobsen FM, Sack DA, Rosenthal NE: Eye versus skin phototherapy of seasonal affective disorder. American Journal of Psychiatry 144: 753-757.

38. Wehr TA, Sack DA, Rosenthal NE: Reverse seasonal affective disorder with spring-summer depression and fall-winter hypomania: possible relationship to environmental

39. Mendelson WB, Sack DA, James SP, Martin JV, Wagner R, Garnett D, Milton J, Wehr TA: Frequency analysis of the sleep EEG in depression. Psychiatry Research June 1987.

40. James SP, Mendelson WB, Sack DA, Rosenthal NE, Wehr TA: The effect of melatonin on normal sleep. Neuropsychopharmacology, Dec. 1987

41. Sack DA, James SP, Rosenthal NE, Wehr TA: Deficient nocturnal TSH during sleep and sleep deprivation in rapid-cycling manic-depressives. Psychiatry Research, in press.

42. Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA: The diurnal variation in plasma HVA persist by the variation in MHPG is abolished under constant conditions. Archives of General Psychiatry, in press.

43. Jacobsen FM, Sack DA, Wehr TA, Rogers S, Rosenthal NE: Neuroendocrine responses to 5-hydroxytryptopha in seasonal affective disorder. Archives of General Psychiatry, in press.

44. ÿJacobsen FM, Wehr TA, Skwere RG, Sack DA, Rosenthal NE: Morning versus midday phototherapy of seasonal affective disorder. American Journal of Psychiatry, in press.

45. Golden RN, Morris JE, Sack DA: Combined lithium-tricyclic treatment of obsessive-compulsive disorder. Biological Psychiatry, in press.

46. Wehr TA, Sack DA: Sleep disruption: A treatment for depression and a cause of mania. Psychiatric Annals, in press.

47. Sack DA, Rosenthal NE, Wehr TA: Biological rhythms in psychiatry, in Psychopharmacology: The Third Generation of Progress, Meltzer HY, editor, Raven Press, NY, 1987.

48. Environmental and behavioral influences on affective illness. Acta Psychiatrica Scandinavica, in press.

49. Jacobsen FM, Sack DA, James SP: Delirium induced by verapramil {letter}. American Journal Psychiatry, Feb. 1987.

50. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW: Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. American Journal Psychiatry, Feb. 1988.

51. Sack DA, Duncan W, Rosenthal NE, Mendelson WE, Wehr TA: The timing and duration of sleep in partial sleep deprivation therapy of depression. Acta Psychiatrica Scandinavica, Feb. 1988.

52. Wehr TA, Rosenthal NE, Sack DA: Environmental and behavioral influences on affective illness. Acta Psychiatrica Scandinavica Suppl., 1988.

53. Rosenthal NE, Skwerer RG, Sack DA, Duncan CC, Jacobsen FM, Tamarkin L, Wehr TA: Biological effects of morning-plus-evening bright light treatment of seasonal affective disorder. Psychopharmacol Bull, 1987.

54. Schulz PM, Goldberg S, Wehr TA, Sack DA, Kasper S, Rosenthal NE: Personality as a dimension of summer and winter depression. Psychopharmacol Bull, 1988.

55. Kasper S, Sack DA, Wehr TA, Kick H, Voll G, Vieira A: Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression. Biol Psychiatry, Oct. 1988

56. Skwerer RG, Jacobsen FM, Duncan CC, Kelly KA, Sack DA, Tamarkin L, Gaist PA, Kasper S, Rosenthal NE: Neurobiology of seasonal affective disorder and phototherapy. J. Biol Rythms, 1988.

57. Rosenthal NE, Sack DA, Skwerer RG, Jacobsen FM, Wehr TA: Phototherapy for seasonal affective disorder. J. Biol Rhythms, 1988.

58. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G: Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. American Journal Psychiatry, 1988.

59. Rosenthal NE, Jocobson FM, Sack DA, Arendt J, James SP, Parry BL, Wehr TA: Atenolol in seasonal affective disorder: a test of the melatonin hypothesis. American Journal Psychiatry, 1988.

60. Parry BL, Mendelson WB, Duncan WC, Sack DA, Wehr TA: Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res, 1989.

61. Sack DA: ?No More Secrets, No More Shame? Understanding Sexual Abuse and Emotional Disorders. PIA Press, Washington D.C., 1990.

62. James SP, Sack DA, Rosenthal NE, Mendleson WB, Wehr TA: The effect of melatonin on polygraphically monitored sleep. Neuropsychopharmacology. 1990 Feb;3(1):19-23.

63. Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E; DHEA-Alzheimer?s Disease Collaborative Research. Neurology. 2003 Apr 8;60(7):1071-6.

Submitted for publication:

64. Rosenthal NE, Sack DA, Carpenter CJ, Van Sant D, James SP, Wehr TA: The Weekly Mood Inventory: A self-rating scale for the longitudinal evaluation of seasonal affective disorder (SAD).

65. Rosenthal NE, Carpenter CJ, Sack DA, Jacobsen FM, James SP, Wehr TA: The placebo effect and other methodological issues in phototherapy studies of seasonal affective disorder.